Although trimethoprim-sulfamethoxazole (TMP-SXT) is considered the first-line therapy for Stenotrophomonas maltophilia infections, there is debate on the use of the bacteriostatic drug in serious infections, and recently, there has been an increasing occurrence of acquired resistance to TMP-SXT. In the present study, the effect of efflux pump inhibitors on the susceptibility of TMP-SXT and other antibiotics were investigated in S. maltophilia complex. The sul and/or dfrA genes were identified in only up to 27.8% of all 36 TMP-SXT-resistant S. maltophilia complex isolates. Thus, TMP-SXT resistance in S. maltophilia was not explained completely by the presence of sul and dfrA genes. Carbonyl cyanide-m-chlorophenylhydrazone (CCCP) decreased the minimum inhibitory concentration (MIC) of TMP-SXT by eight to 128 folds in all 14 isolates. In contrast, 2,4-dinitrophenol (DNP), phenyl-arginine-β-naphthylamide (PAβN), and reserpine did not reduce the MIC of TMP-SXT. In addition to TMP-SXT, slight decrease in MICs was observed for tigecycline and piperacillin/tazobactam by CCCP (by two folds) in one isolate. Although efflux pump may play a role in TMP-SXT resistance in S. maltophilia, inhibition of the efflux pump could be done by active proton pore.
INTRODUCTION
Stenotrophomonas maltophilia is generally associated with septicemia and respiratory infections, especially in immunocompromised patients and cystic fibrosis patients (1) . It exhibits resistance to many commonly used broadspectrum antibiotics and treatment recommendations are controversial, partly due to a lack of consistency in susceptibility testing methods and poor correlation between in vitro studies and clinical outcome (1) . S. maltophilia isolates are often highly resistant to most of the currently used antimicrobial agents, including carbapenems, aminoglycosides, and fluoroquinolones, because S. maltophilia has high intrinsic resistance to a variety of structurally unrelated antimicrobial agents, including β-lactams, aminoglycosides, and quinolones. A variety of antimicrobial resistance mechanisms, including efflux pumps and integrons, have been reported in S. maltophilia (2) . Europe to 28.3% in Turkey (3~5). In our study, the rate of TMP-SXT-resistant S. maltophilia was 30.5% (6) . In addition, it was shown S. maltophilia identified in microbiology labs includes multiple species, forming S. maltophilia complex (6).
Although only a few studies showed the mechanisms of TMP-SXT resistance-three main mechanisms have been suggested to be involved in bacterial resistance to the antibiotics-modification of the target and, enzymatic inactivation of the antibiotic, or default of its accumulation within the cell (lack of entry or efflux systems). Some bacteria have a decreased permeability for TMP-SXT or have a target enzyme with decreased affinity for the drugs. As examples, resistance of Pneumocystis jirovecii to SXT after the administration of TMP-SXT has been correlated with dihydropteroate synthase gene mutations (7), while dihydrofolate reductase gene mutations can account for high level resistance in other organisms such as Enterococcus faecalis and Campylobacter jejuni (8) . Several studies performed on S. maltophilia isolates have shown that sul1 genes associated with class 1 integrons are the major mechanism of TMP-SXT resistance (7) . A study indicated that the sul1 gene, in combination with dfrA17 and dfrA12 gene cassettes and sul2 genes lead to a high rate of SXT resistance (9) .
These genes are known to be mechanism of trimethoprimsulfamethoxazole resistance. In E. faecalis, intrinsic resistance to SXT has been found, which are typically auxotrophic for folic acid (10) . In addition, some bacteria species (e.g., including Pseudomonas aeruginosa) have an active efflux mechanism to eliminate the drug from the cell (11) . Although the intrinsic resistance to multiple unrelated antibiotics and disinfectants of Gram-negative bacteria is mediated by innate mechanisms and is principally defined by expression of efflux pump systems and porins (12) , only one study showed that SmeABC pumps were related to increase the MIC of TMP-SXT, ticarcillin-clavulanate, and ciprofloxacin (1).
There are five families of multidrug resistance (MDR) efflux pumps: the resistance nodulation division (RND) family, the major facilitator superfamily (MFS), the staphylococcal multidrug resistance (SMR) family, the multidrug and toxic compound extrusion (MATE) family and the ATPbinding cassette (ABC) family (13) . In addition, many strains of S. maltophilia possess efflux pumps, which confer further resistance to multiple antibacterial classes (14, 15) .
In the present study, the effect of efflux pump inhibitors on the susceptibility of TMP-SXT and other antibiotics were investigated in S. maltophilia complex. The present study plans to correlate the TMP-SXT resistance patterns of the S. maltophilia complex with their antimicrobial efflux mechanisms.
MATERIALS AND METHODS

Bacterial isolates
All 36 TMP-SXT resistant S. maltophilia complex were investigated to detect sul1, sul2 and dfrA genes. Fourteen isolates (seven TMP-SXT resistant isolates and seven TMP-SXT susceptible isolates) among 118 clinical isolates tentatively identified as S. maltophilia complex were included in efflux pump inhibitors study. They were collected from seven tertiary-care hospitals in Korea from 2007 to 2011 and were identified conventionally using VITEK2 systems in the hospitals' clinical microbiology labs.
Antimicrobial susceptibility test
In vitro susceptibility testing was performed with isolates identified as S. maltophilia complex in this study using the broth microdilution method according to CLSI guidelines (16) . 
Polymerase chain reaction (PCR) for detecting sul and dfrA genes
The presence of sul1, sul2 and dfrA genes in 36 TMP-SXT resistant strains were assessed using the primers shown in Table 1 which were designed for this study using the Primer 3 online software http://frodo.wi.mit.edu/primer3/.
Total DNA was extracted by suspending several overnight colonies in 0.5 ml of double-distilled water and heating the mixture at 100℃ for 10 min. The PCR cycling parameters were as follows: 95℃ for 5 min, followed by 35 cycles of 95℃ for 1 min, 55℃ for 1 min and 72℃ for 1~4 min depending on the sequence to be amplified, and ending with 10 min incubation at 72℃. PCR fragment length estimation was by reference to a 100 bp DNA size standard. Confirmation of the electrophoresis sizing observations was by DNA sequencing of selected PCR products.
Effect of efflux inhibitors on minimum inhibitory concentration (MIC) levels of Trimethoprim-sulfamethoxazole
To determine the extent of the efflux pump mediated TMP-SXT resistance in S. maltophilia isolates, MIC levels for TMP-SXT were determined using broth microdilution 
RESULTS
Detecting sul1, sul2 and dfrA genes
The sul1 gene was detected in five TMP-SXT-resistant S. maltophilia isolates. The dfrA1, dfrA5, and dfrA12/13 genes were positive in one, three, and seven, respectively. The sul2 and dfrA17 gene were not detected in all TMP-SXT resistant isolates. Three isolates harbored both sul1 and dfrA12/13 genes with high resistance to TMP-SXT (MIC, 16:304, >64:1216) and levofloxacin (MIC, 32 mg/l). Both dfrA5 and dfrA12/13 were detected in two isolates, which were also resistant to levofloxacin. One isolate showed positivity for sul1 and dfrA1, however it was not resistant to levofloxacin (Table 2) . maltophilia, but inhibition of the efflux pump could be done by active proton pore.
